Development of a new culture system for human lymphokine-activated killer cells: comparison with a conventional static culture method.
We recently developed a new culture system based on dialysis perfusion (designated JCC-device) for the generation and expansion of human lymphokine-activated killer (LAK) cells (Murata et al., 1990). More recently we have scaled up the volume of the culture vessel of the JCC-device from 100 ml to 400 ml for clinical use. In the present study, using this new 400 ml JCC-device, we cultured human lymph node lymphocytes (LNL) obtained from 8 surgical patients with primary lung cancer, and investigated the cellular characteristics in comparison with a conventional batchwise culture system using tissue culture dishes. With the JCC-device, the cell density reached a maximum 2.7 x 10(7) cells/ml with greater than 90% viability by the appropriate exchange of perfusion medium and by making additions at the appropriate intervals for recombinant interleukin-2 (rIL-2). The expansion fold of LNL with the JCC-device, ranging 6.6- to 19.2-fold (mean 13.8-fold), was not significantly different from that in dish cultures. There was no marked difference in cell surface phenotypes between the two culture systems in 7 out of 8 cases. As for LAK activity of LNL, the JCC culture was either superior or equal in 4 out of 8 cases, but inferior in the other 4 cases to the conventional dish cultures. In the latter cases, the usage of serum for the JCC culture was limited, which might have resulted in the low LAK activity.(ABSTRACT TRUNCATED AT 250 WORDS)
Murata
M
M
Department of Immunology, Kyushu University, Fukuoka, Japan.
Yano
T
T
Yoshino
I
I
Togami
M
M
Sogabe
M
M
Yasumoto
K
K
Sugimachi
K
K
Kimura
G
G
Nomoto
K
K
D002452:Cell Count; D002455:Cell Division; D002460:Cell Line; D002470:Cell Survival; D002478:Cells, Cultured; D046508:Culture Techniques / Q000295:instrumentation / Q000379:methods*; D003602:Cytotoxicity, Immunologic; D006801:Humans; D007376:Interleukin-2; D015979:Killer Cells, Lymphokine-Activated / Q000166:cytology* / Q000276:immunology; D008175:Lung Neoplasms / Q000473:pathology; D008198:Lymph Nodes / Q000473:pathology; D011994:Recombinant Proteins
D007376:Interleukin-2; D011994:Recombinant Proteins